VMAT for early pancreatic adenocarcinoma in case where surgery is contraindicated

Main Article Content

Cholakiet Khorprasert, MD
Prasert Lertsanguansinchai, MD
Napapat Amornwichet, MD
Wirote Loasoontornsiri, MD
Supranee Supanunt
Krittiya Chantharawanitkul
Kriangdate Boonlerluk
Chulee Vannavijit
Wutthichai Boonrat
Patcharapa Trikaewcharoen
Puncharat Sakthumjaroen

Abstract

There are several methods for managing pancreatic cancer. Surgical resection gives the best chance for a possible cure in the early stages of the disease. However only 10-20% of patients present with potentially resectable pancreatic cancer. Chemotherapy is the treatment of choice for the advanced metastatic disease. For locally advanced, inoperable pancreatic cancer, combined chemotherapy and radiation is the preferred treatment.1 In the case of patients who have contraindications for surgery, concurrent chemoradiation may be chosen2. The patient in this study, was a case of adenocarcinoma at the pancreatic head, stage T1N0M0, with underlying heart disease; she thus was contraindicated for a major operation. The treatment plan was chemoradiation, using VMAT radiotherapy technique with a radiation dose of 45Gy in 25 fractions and oral Xeloda.

Downloads

Download data is not yet available.

Article Details

How to Cite
1.
Khorprasert C, Lertsanguansinchai P, Amornwichet N, Loasoontornsiri W, Supanunt S, Chantharawanitkul K, Boonlerluk K, Vannavijit C, Boonrat W, Trikaewcharoen P, Sakthumjaroen P. VMAT for early pancreatic adenocarcinoma in case where surgery is contraindicated. BKK Med J [Internet]. 2018Feb.18 [cited 2020Jul.16];1(1):10. Available from: https://he02.tci-thaijo.org/index.php/bkkmedj/article/view/217622
Section
Case Report

References

1. Sener SF, Fremgen A, Menck HR, Winchester DP. Pan- creatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the National Cancer Database.J Am Coll Surg 1999;189:1-7
2. https://www.elekta.com/assets/vmat/case_studies/0781% 2009-08%20VMAT%20Seattle.pdf
3. https://www.isrrt.org/images/isrrt/Astro_WhitePaper_ Singles_release.pdf
4. Boggula F, Lorenz F, Muller L, et al. Experimental validation of 3D dose verification system for intensities modulated arc therapies Phys. Med. Bio. Oct 2010;7;55 (19):5619-5633